Overall, systematic p53 (TP53) acetylation and SIRT1 inactivation initially play a pivotal role and eventually rewire downstream global interaction networks toward anti-tumor growth through the arrest of cell cycle progression, while promoting pro-cellular death conditions via the dysfunction of DNA damage repair and pro-apoptotic actions. This evidence concerns the gene TP53 and neoplasm.